Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Avg
|
|
New words:
absence, add, agility, approach, Arginine, Asian, awarded, aware, Biomedical, biotech, borrowing, brentuximab, broad, burden, Chinese, cHL, choice, classical, concise, correct, countersued, declaratory, Deiminase, destructive, disciplined, Division, Dutch, duty, ehf, entrepreneurial, EPO, evident, examination, fiduciary, firm, force, Hodgkin, Honjo, immunoscience, inventorship, JCCP, Keytruda, Kingdom, Korman, leadership, lease, lesser, leverage, long, longest, lymphoma, maintain, maintained, MDL, monetary, monohydrate, Mylan, opposition, PAD, Padlock, par, permanently, petitioner, plateau, platinum, practicable, preemption, prepaid, presence, pretreated, prospective, PTC, pursue, reacquire, readily, reconsideration, Revlimid, revoked, rose, SCCHN, stem, stipulation, sued, Taiwan, top, treasury, unnamed, vedotin, ViiV, withheld
Removed:
abatacept, achievement, acquire, adequately, administered, advance, aggregate, aimed, amortized, approximate, assumed, ASV, asymptomatic, BCV, benchmark, beta, biopharma, Brazil, Bydureon, calcium, calculation, Calibr, Canada, carrying, CI, close, closing, collaborate, collect, combining, congestive, construct, continued, contract, create, daewoong, DCV, delivered, developing, discontinued, discount, discovering, disease, domestic, dual, earned, EGFR, ejection, eligible, entecavir, equal, equally, erosion, event, evolution, evolve, exercised, exit, exposure, factoring, FCPA, filling, floating, forecast, forecasted, formulation, fourth, fraction, gene, globally, Hanmi, hazard, heart, hedged, highly, imatinib, ImClone, immunology, immunotherapy, improve, inception, increasing, Indiana, ineffective, infected, infection, initiated, innate, inoperable, inquiry, instrument, invoiced, ipilimumab, Italy, IV, joint, key, KGaA, Korean, leading, located, manufacture, master, Mexico, minimally, modulating, molecule, monitored, Mount, Myalept, negative, nivolumab, objective, observed, occurring, offsetting, Ohio, Onglyza, open, originally, Otsuka, oversight, payable, peer, percentage, performed, personnel, platform, Portugal, privately, promotional, prostate, Prostvac, qualifying, RA, ratably, ratio, recorded, recourse, redemption, regulator, remeasured, remeasuring, reserve, responsibility, restore, restricted, restructuring, retain, retirement, returned, revised, ruled, satisfying, sensor, separately, shift, shown, simplified, small, sovereign, standalone, standpoint, substantially, sulfate, Symlin, symptomatic, synthesize, system, tablet, technology, temporarily, terminate, TGF, transformation, translation, Tribunal, ultimately, uncollectibility, underlying, uniQure, Valeant, variability, Vernon, vest, virology, weighted, workforce
Filing tables
Filing exhibits
Related press release
BMY similar filings
Filing view
External links